2m 2m 2m 2m 2m 2m 2m
PHARMNG ADS (PHAR)
NASDAQ
$10.61+$0.96 (+9.90%)
Price as of Oct 22, 2026 7:30 PM EDT- $683.0MMarket Cap
- -26.34%1-Year Change
- BiotechnologyIndustry
PHARMNG ADS (PHAR)
$10.61+$0.96 (+9.90%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 376.1M +26.56% | 297.2M +21.15% | 245.3M +19.30% | 205.6M +3.39% | |
Cost of Revenue | 45.5M +28.53% | 35.4M +40.41% | 25.2M +43.56% | 17.6M -16.93% | |
Gross Profit | 330.6M +26.29% | 261.8M +18.94% | 220.1M +17.04% | 188.1M +5.81% | |
Sales and Marketing Expense | 131.0M +10.26% | 118.8M -4.23% | 124.0M +44.57% | 85.8M +44.34% | |
Research and Development Expense | -100.4M +20.71% | -83.1M +20.65% | -68.9M +31.19% | -52.5M -25.35% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 80.0M +13.17% | 70.7M +26.44% | 55.9M +21.43% | 46.0M +24.46% | |
Operating Profit | 25.8M +399.76% | -8.6M +60.03% | -5.4M -129.55% | 18.2M +34.45% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 6.5M +199.86% | 2.2M -90.68% | 23.3M +60.77% | 14.5M N/A | |
Income before Taxes | 2.5M +121.43% | -11.8M +12.26% | -10.5M -177.14% | 13.7M -14.52% | |
Income Taxes | 10.3M +207.85% | 3.3M +328.76% | -1.5M -211.50% | 1.3M -81.46% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 2.5M +121.43% | -11.8M +12.26% | -10.5M -177.14% | 13.7M -14.52% | |
Net Income from Continuing Operations Applicable to Common | 2.5M +121.43% | -11.8M +12.26% | -10.5M -177.14% | 13.7M -14.52% | |
Basic EPS and Net Income | 0.004 +122.22% | -0.02 +12.50% | -0.02 -176.19% | 0.02 -16.00% | |
Diluted EPS and Net Income | 0.004 +122.22% | -0.02 +12.50% | -0.02 -184.21% | 0.02 -17.39% | |
Basic Weighted Average Shares | 688.8M +2.60% | 671.3M +2.18% | 657.0M +1.29% | 648.7M +1.04% | |
Diluted Weighted Average Shares | 688.8M +2.60% | 671.3M +2.18% | 657.0M +1.29% | 648.7M +1.04% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 145.3M +164.46% | 54.9M -11.01% | 61.7M -70.22% | 207.3M +8.03% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 145.3M +164.46% | 54.9M -11.01% | 61.7M -70.22% | 207.3M +8.03% | |
Total Current Assets | 299.5M +7.55% | 278.4M -11.98% | 316.3M +14.00% | 277.5M +11.25% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 7.2M -6.70% | 7.8M -19.99% | 9.7M -6.76% | 10.4M -21.40% | |
Total Long-Term Assets | 200.5M +64.96% | 121.5M -17.04% | 146.5M -1.20% | 148.3M +0.29% | |
Total Assets | 500.0M +25.00% | 400.0M -13.58% | 462.9M +8.70% | 425.8M +7.17% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 115.8M +56.89% | 73.8M -5.34% | 78.0M +30.60% | 59.7M +27.64% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 107.1M +1.85% | 105.1M -36.71% | 166.1M +2.88% | 161.5M +2.43% | |
Total Liabilities | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Retained Earnings | -273.0M -0.91% | -275.5M +3.86% | -265.3M +3.44% | -256.4M -6.13% | |
Total Stockholders Equity | 277.1M +25.35% | 221.1M +1.04% | 218.8M +6.91% | 204.6M +6.08% | |
Total Shares Outstanding | 701.7M +3.14% | 680.3M +1.38% | 671.1M +2.24% | 656.3M +1.17% | |
Cash Flow | |||||
Cash from Operating Activities | 54.7M +3,147.80% | -1.8M -89.63% | -17.3M -177.04% | 22.5M -40.65% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 26.3M -16.97% | 31.6M +124.44% | -129.4M -2,530.73% | 5.3M +124.98% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.5M +104.34% | -34.4M +3,212.03% | -1.0M -79.14% | -5.0M -82.17% | |
Financials Ratio | |||||
Gross Margin | 87.90% -0.21% | 88.09% -1.82% | 89.72% -1.90% | 91.46% +2.34% | |
Operating Margin | 6.87% +336.85% | -2.90% +32.10% | -2.20% -124.76% | 8.87% +30.04% | |
Return on Assets | 0.56% +120.55% | -2.74% +15.62% | -2.37% -171.45% | 3.32% -23.35% | |
Return on Equity | 1.02% +118.92% | -5.38% +8.07% | -4.98% -172.43% | 6.88% -26.40% | |
Revenue Growth | 26.56% +25.58% | 21.15% +9.56% | 19.30% +468.66% | 3.39% -52.16% | |
Current Ratio | 2.59 -31.45% | 3.77 -7.01% | 4.06 -12.72% | 4.65 -12.84% | |
Cash Ratio | 1.25 +68.56% | 0.74 -5.99% | 0.79 -77.20% | 3.47 -15.36% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow